Everlife Holdings Pte Ltd (“Everlife”), a leading market access and distribution company in India and South East Asia, has announced the completion of its acquisition of Biofrontier Technology Pte Ltd (“Biofrontier”), a premier provider of calibration services in Singapore. Biofrontier was established in 2003 and over the last 18 years has built up a significant reputation as a reliable provider of quality calibration services for scientific equipment. The company was the first company in Singapore to receive ISO/IEC 17025 accreditation for pipette calibration, and today is fully accredited to calibrate a wide range of instruments including weighing balances, thermocyclers, spectrophotometers, centrifuges, timers, heating blocks, digital thermometers and others under the umbrella brand BioCalTM Services.
Everlife already holds a strong position with customers running Life Science and Industrial laboratories, many of which require dedicated service teams to provide technical support. Biofrontier’s portfolio of calibration services is highly complementary to this business and the acquisition would allow Everlife to expand its service portfolio to customers to include calibration services across the region.
Raman Gandotra, CEO of Everlife, said: “I’m thrilled to welcome the Biofrontier team to the Everlife family, and to learn how we can bring this value-added service to customers. I believe there is significant opportunity for us to invest and grow this in the region.”
Mr. Sim Koon Meng, Managing Director of Biofrontier, commented: “We are excited at the opportunity and resources that Everlife brings, and we are looking forward to working together to bring high quality calibration services to more customers in Singapore and abroad.”
About Everlife
Everlife is one of the leading providers of products and solutions to clinical and scientific laboratories in South and South East Asia. By combining our technical expertise with a deep understanding of Asia and a passionate and results-driven approach to business, we aim to improve outcomes for our communities and to improve business performance for customers and principals. The Group represents over 250 principals and a team of almost 1000 employees that operate across 7 countries. Everlife is part of the Everstone Group and Cure Capital is a minority investor. To learn more, visit www.everlifeasia.com or visit us on LinkedIn.
About Biofrontier Technology Biofrontier Technology is Singapore’s leading provider for volumetric calibrations and aims to become Singapore’s leading partner for measurement solutions. Our dedicated and expert teams in sales, applications, and service, allows us to provide unparalleled support to customers to maintain their measurement systems in superior condition, to perform at its peak in both aspects of accuracy and precision, and to ensure every degree of dependability. To learn more, visit www.biofrontiertechnology.com.